Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Registry-based Randomized Controlled Trial of Moderate-intensity Statin Therapy vs. Individualized Low-density Lipoprotein Cholesterol Target-based Therapy for Primary Prevention of Cardiovascular Events in Patients 70 Years of Age or Older With Type 2 Diabetes (iTARGET-Elderly Study)

NCT07359105 is registered in ClinicalTrials.gov with Sin Gon Kim as lead sponsor.

NCT NCT07359105
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07359105 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Registry-based Randomized Controlled Trial of Moderate-intensity Statin Therapy vs. Individualized Low-density Lipoprotein Cholesterol Target-based Therapy for Primary Prevention of Cardiovascular Events in Patients 70 Years of Age or Older With Type 2 Diabetes (iTARGET-Elderly Study)
Lead sponsor
Sin Gon Kim
Phase
Not applicable
Overall status
Recruiting
Start date
March 9, 2026
Completion date
December 31, 2029
Enrollment
2,186 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

dyslipidemia associated with type ii diabetes mellitus